SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-22-000019
Filing Date
2022-04-27
Accepted
2022-04-27 16:19:52
Documents
16
Period of Report
2022-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20220427.htm   iXBRL 8-K 60923
2 EX-99.1 amgenq12022earningsrelease.htm EX-99.1 481981
3 EX-99.2 amgn-ex992_2022331xq1.htm EX-99.2 29146
8 GRAPHIC amgenlogoa14.jpg GRAPHIC 6206
  Complete submission text file 0000318154-22-000019.txt   820275

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20220427.xsd EX-101.SCH 3091
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20220427_def.xml EX-101.DEF 17327
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20220427_lab.xml EX-101.LAB 33559
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20220427_pre.xml EX-101.PRE 17615
10 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20220427_htm.xml XML 14887
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 22859878
SIC: 2836 Biological Products, (No Diagnostic Substances)